MCP-1and IL-1β expression in the myocardia of two young patients with Type 1 diabetes mellitus and fatal diabetic ketoacidosis

Experimental and Molecular Pathology

Volumn 96, Issue 1, 2014, Pages 71-79

  Niu, Jianli ^a   Gilliland, M G F ^b   Jin, Zhuqing ^c   Kolattukudy, Pappachan E ^a   Hoffman, William H ^d  

^a UNIVERSITY OF CENTRAL FLORIDA COLLEGE OF MEDICINE   (United States)

^b EAST CAROLINA UNIVERSITY   (United States)

^c ZHEJIANG CHINESE MEDICAL UNIVERSITY   (China)

^d MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

Diabetic cardiomyopathy; Diabetic ketoacidosis; IL 1 ; MCP 1; Obesity; Type 1 diabetes mellitus

Indexed keywords

3 NITROTYROSINE; COLLAGEN; INTERLEUKIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; RAMIPRIL;

ADOLESCENT; ADULT; APOPTOSIS; ARTICLE; AUTOPSY; BRAIN TOMOGRAPHY; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIABETIC CARDIOMYOPATHY; DIABETIC KETOACIDOSIS; FIBROSING ALVEOLITIS; HEART ARREST; HEART VENTRICLE HYPERTROPHY; HUMAN; HUMAN TISSUE; INSULIN DEPENDENT DIABETES MELLITUS; MALE; NAUSEA AND VOMITING; NICK END LABELING; OBESITY; OXIDATIVE STRESS; PATHOGENESIS; PROTEIN EXPRESSION; WEIGHT REDUCTION;

DIABETIC CARDIOMYOPATHY; DIABETIC KETOACIDOSIS; IL-1Β; MCP-1; OBESITY; TYPE 1 DIABETES MELLITUS;

ADOLESCENT; ADULT; APOPTOSIS; CHEMOKINE CCL2; DIABETES MELLITUS, TYPE 1; DIABETIC KETOACIDOSIS; FATAL OUTCOME; HUMANS; HYPERTROPHY; IMMUNOENZYME TECHNIQUES; IN SITU NICK-END LABELING; INFLAMMATION; INTERLEUKIN-1BETA; MALE; MYOCARDIUM; OXIDATIVE STRESS; YOUNG ADULT;

EID: 84891753120     PISSN: 00144800     EISSN: 10960945     Source Type: Journal    
DOI: 10.1016/j.yexmp.2013.11.001     Document Type: Article

References (76)

1. Aljada A., Ghanim H., Saadeh R., Dandona P. Insulin inhibits NFkappaB and MCP-1 expression in human aortic endothelial cells. J. Clin. Endocrinol. Metab. 2001, 86(1):450-453.
2. Aragno M., Mastrocola R., Alloatti G., Vercellinatto I., Bardini P., Geuna S., Catalano M.G., Danni O., Boccuzzi G. Oxidative stress triggers cardiac fibrosis in the heart of diabetic rats. Endocrinology 2008, 149(1):380-388.
3. Ares-Carrasco S., Picatoste B., Benito-Martin A., Zubiri I., Sanz A.B., Sanchez-Nino M.D., Ortiz A., Egido J., Tunon J., Lorenzo O. Myocardial fibrosis and apoptosis, but not inflammation, are present in long term experimental diabetes. Am. J. Physiol. Heart Circ. Physiol. 2009, 297(6):H2109-H2119.
4. Asgari E., Le Friec G., Yamamoto H., Perucha E., Sacks S.S., Kohl J., Cook H.T., Kemper C. C3a modulates IL-1beta secretion in human monocytes by regulating ATP efflux and subsequent NLRP3 inflammasome activation. Blood PMID 2013, 23878142.
5. Aukrust P., Ueland T., Muller F., Andreassen A.K., Nordoy I., Aas H., Kjekshus J., Simonsen S., Froland S.S., Gullestad L. Elevated circulating levels of C-C chemokines in patients with congestive heart failure. Circulation 1998, 97(12):1136-1143.
6. Bodiga V.L., Eda S.R., Bodiga S. Advanced glycation end products: role in pathology of diabetic cardiomyopathy. Heart Fail. Rev. 2013, (2013 Feb 13. PMID: 23404649).
7. Boudina S., Abel E.D. Diabetic cardiomyopathy revisited. Circulation 2007, 115(2):3213-3223.
8. Bracey N.A., Beck P.L., Muruve D.A., Hirota S.A., Guo J., Jabagi H., Wright J.R., Macdonald J.A., Lees-Miller J.P., Roach D., Semeniuk L.M., Duff H.J. The Nlrp3 inflammasome promotes myocardial dysfunction in structural cardiomyopathy through interleukin-1 beta. Exp. Physiol. 2013, 98(2):462-472.
9. Brown R.D., Ambler S.K., Mitchell M.D., Long C.S. The cardiac fibroblast: therapeutic target in myocardial remodeling and failure. Ann. Rev. Pharmacol. Toxicol. 2005, 45:657-687.
10. Buyukgebiz, A., Saylam, G., Dundar, B., Bober, E., Unal, N., Akcoral, A., 2000. 13 (8): 1143-1146.
11. Cai L., Kang Y.J. Cell death and diabetic cardiomyopathy. Cardiovasc. Toxicol. 2003, 3(3):219-228.
12. Ceriello A., dello Russo P., Amstad P., Ceruti P. High glucose induces antioxidant enzymes in human endothelial cells in culture. Evidence linking hyperglycemia and oxidative stress. Diabetes 1996, 45(4):471-477.
13. Cihakova D., Rose N.R. Pathogenesis of myocarditis and dilated cardiomyopathy. Adv. Immunol. 2008, 99:95-114.
14. Dabkowski E.R., Baseler W.A., Williamson C.L., Powell M., Razunguzwa T.T., Frisbee J.C., Hollander J.M. Mitochondrial dysfunction in the type 2 diabetic heart is associated with alterations in spatially distinct mitochondrial proteomes. Am. J. Physiol. Heart Circ. Physiol. 2010, 299(2):H529-H540.
15. Dalton R.R., Hoffman W.H., Passmore G.G., Martin S.L. Plasma C-reactive protein levels in severe diabetic ketoacidosis. Ann. Clin. Lab. Sci. 2003, 33(4):435-442.
16. Damas J.K., Aukrust P., Ueland T., Odegaard A., Eiken H.G., Gullestad L., Sejersted O.M., Christensen G. Monocyte chemoattractant protein-1 enhances and interleukin-10 suppresses the production of inflammatory cytokines in adult rat cardiomyocytes. Basic Res. Cardiol. 2001, 96(4):345-352.
17. Das U.N. Insulin: an endogenous cardioprotector. Curr. Opin. Crit. Care 2003, 9(5):375-383.
18. Dasu M.R., Jialal I. Free fatty acids in the presence of high glucose amplify monocyte inflammation via Toll-like receptors. Am. J. Physiol. Endocrinol. Metab. 2011, 300(1):E145-E154.
19. Dobaczewski M., Frangogiannis N.G. Chemokines and cardiac fibrosis. Front. Biosci. 2009, 1:391-405.
20. Espinola-Klein C., Gori T., Blankenberg S., Munzel T. Inflammatory markers and cardiovascular risk in the metabolic syndrome. Front. Biosci. 2011, 16:1663-1674.
21. Fernandez-Real J.M., Ricart W. Insulin resistance and chronic cardiovascular inflammatory syndrome. Endocr. Rev. 2003, 24(3):278-301.
22. Frustaci A., Kajstura J., Chimenti C., Jakoniuk I., Leri A., Maseri A., Nadal-Ginard B., Anversa P. Myocardial cell death in human diabetes. Circ. Res. 2000, 87(12):1123-1132.
23. Gavrilin M.A., Deucher M.F., Boeckman F., Kolattukudy P.E. Monocyte chemotactic protein 1 upregulates IL-1beta expression in human monocytes. Biochem. Biophys. Res. Commun. 2000, 277(1):37-42.
24. Gordin D., Forsblom C., Ronnback M., Parkkonen M., Waden J., Hietala K., Groop P.H. Acute Hyperglycaemia Induces an Inflammatory Response in Young Patients with Type 1 Diabetes 2008.
25. Grundy S.M., Benjamin I.J., Burke G.L., Chait A., Eckel R.H., Howard B.V., Mitch W., Smith S.C., Sowers J.R. Diabetes and cardiovascular disease: a statement for healthcare professionals from the American Heart Association. Circulation 1999, 100(10):1134-1146.
26. Gullestad L., Ueland T., Vinge L.E., Finsen A., Finsen A., Yndestad A., Aukrust P. Inflammatory cytokines in heart failure: mediators and markers. Cardiology 2012, 122(1):23-35.
27. Gunczler P., Lanes R., Soros A., Verdu L., Ramon Y., Guevara B., Beer N. Coronary artery calcification, serum lipids, lipoproteins, and peripheral inflammatory markers in adolescents and young adults with type 1 diabetes. J. Pediatr. 2006, 149(3):320-323.
28. Hiramatsu S., Komori K., Mori E., Ogo A., Maruyamas S., Kato S. A case of fulminant type 1 diabetes mellitus accompanied by myocarditis. Endocr. J. 2011, 58(7):2011.
29. Hoerger T.J., Ahmann A.J. The impact of diabetes and associated cardiometabolic risk factors on members: strategies for optimizing outcomes. J. Manag. Care Pharm. 2008, 14(1 Suppl. C):S2-S14.
30. Hoffman W.H., Cheng C., Passmore G.G., Carroll J.E., Hess D. Acetoacetate increases expression of intercellular adhesion molecule-1 (ICAM-1) in human brain microvascular endothelial cells. Neurosci. Lett. 2002, 334(2):71-74.
31. Hoffman W.H., Burek C.L., Waller J.L., Fisher L.E., Khichi M., Mellick L.B. Cytokine response to diabetic ketoacidosis and its treatment. Clin. Immunol. 2003, 108:175-181.
32. Hoffman W.H., Kappler F., Passmore G.G., Mehta R. Diabetic ketoacidosis and its treatment increase plasma 3-deoxyglucosone. Clin. Biochem. 2003, 36:269-273.
33. Hoffman W.H., Stamatovic S.M., Andjelkovic A.V. Inflammatory mediators and blood brain barrier disruption in fatal brain edema of diabetic ketoacidosis. Brain Res. 2009, 1254:138-148.
34. Hoffman W.H., Passmore G.G., Hannon D.W., Talor M.V., Fox P., Brailer C., Haislip D., Keel C., Harris G., Rose N.R., Fiordalisi I., Cihakova D. Increased systemic Th17 cytokines are associated with diastolic dysfunction in children and adolescents with diabetic ketoacidosis. PLoS One 2013, 8(8). 10.1371/journal.pone.0071905.
35. Ikeda T., Sato K., Kuwada N., Matsumura T., Yamashita T., Kimura F., Hatake K., Ikeda K., Motoyoshi K. Interleukin-10 differentially regulates monocyte chemoattractant protein-1 gene expression depending on the environment in a human monoblastic cell line, UG3. J. Leukoc. Biol. 2002, 72(6):1198-1205.
36. Isales C.M., Min L., Hoffman W.H. Acetoacetate and beta-hydroxybutyrate differentially regulate endothelin-1 and vascular endothelial growth factor in mouse brain microvascular endothelial cells. J. Diabetes Complicat. 1999, 13(2):91-97.
37. Jain S.K., Kannan K., Lim G. Ketosis (acetoacetate) can generate oxygen radicals and cause lipid peroxidation and growth inhibition in human endothelial cells. Free Radic. Biol. Med. 1998, 25(9):1083-1088.
38. Jerath R.S., Burek C.L., Hoffman W.H., Passmore G.G. Complement activation in diabetic ketoacidosis and its treatment. Clin. Immunol. 2005, 116:11-17.
39. Karavanaki K., Karanika E., Georga S., Bartzeliotou A., Tsouvalas M., Konstantopoulos I., Fotinou A., Papassotiriou Cytokine response to diabetic ketoacidosis (DKA) in children with type 1 diabetes (T1DM). Endocr. J. 2011, 58(12):1045-1053.
40. Kiencke S., Handschin R., von Dahlen R., Muser J., Brunner-Larocca H.P., Schumann J., Felix B., Bemeis K., Rickenbacher P. Pre-clinical diabetic cardiomyopathy: prevalence, screening, and outcome. Eur. J. Heart Fail. 2010, 12(9):951-957.
41. Kobayashi Y., Kubo A., Iwano M., Sakaguchi Y., Samejima K., Kyoda Y., Yonemasu K., Hashimoto T. Levels of MCP-1 and GM-CSF mRNA correlated with inflammatory cytokines mRNA levels in experimental autoimmune myocarditis in rats. Autoimmunity 2002, 35(2):97-104.
42. Kobayashi M., Nakamura K., Kusano K.F., Nakamura Y., Ohta-Ogo K., Nagase S., Sakuragi S., Ohe T. Expression of monocyte chemoattract protein-1 in idiopathic dilated cardiomyopathy. Int. J. Cardiol. 2008, 126(3):427-429.
43. Kolattukudy P.E., Quach T., Bergese S., Breckenridge S., Hensley J., Altschuld R., Gordillo G., Klenotic S., Orosz C., Parker-Thomburg J. Myocarditis induced by targeted expression of the MCP-1 gene in murine cardiac muscle. Am. J. Pathol. 1998, 152(1):101-111.
44. Lee D.M., Hoffman W.H., Carl G.F., Khichi M., Cornwell P.E. Lipid peroxidation and antioxidant vitamins prior to, during, and after correction of diabetic ketoacidosis. J. Diabetes Complicat. 2002, 16(4):294-300.
45. Li Y., Heuser J.S., Kosanke S.D., Hemric M., Cunningham M.W. Protection against experimental autoimmune myocarditis is mediated by interleukin-10-producing T cells that are controlled by dendritic cells. Am. J. Pathol. 2005, 167(1):5-15.
46. Luna J., Gilliland M.G.F., Herbert C., Tanenberg R. Postmortem diagnosis of diabetic ketoacidosis presenting as dead in bed. 95th Annual Meeting of the Endo. Soc. June 15-18, San Francisco, CA 2013.
47. Ma H., Li S.Y., Xu P., Babcock S.A., Dolence E.K., Brownlee M., Li J., Ren J. Advanced glycation endproduct (AGE) accumulation and AGE receptor (RAGE) up-regulation contribute to the onset of diabetic cardiomyopathy. J. Cell. Mol. Med. 2009, 13(8B):1751-1764.
48. Maiese K., Morhan S.D., Chong Z.Z. Oxidative stress biology and cell injury during type 1 and type 2 diabetes mellitus. Curr. Neurovasc. Res. 2007, 4(1):63-71.
49. Martire A., Fernandez B., Buehler A., Strohm C., Schaper J., Zimmermann R., Kolattukudy P.E., Schaper W. Cardiac overexpression of monocyte chemoattractant protein-1 in transgenic mice mimics ischemic preconditioning through SAPK/JNK1/2 activation. Cardiovasc. Res. 2003, 57(2):523-534.
50. Mills K.H., Dungan L.S., Jones S.A., Harris J. The role of inflammasome-derived IL-1 in driving IL-17 responses. J. Leukoc. Biol. 2013, 93(4):489-497.
51. Mizushige K., Yao L., Noma T., Kiyomoto H., Yu Y., Hosomi N., Ohmori K., Matsuo H. Alteration in left ventricular diastolic filling and accumulation of myocardial collagen at insulin-resistant prediabetic stage of a type II diabetic rat model. Circulation 2000, 101(6):899-907.
52. Mokuno T., Sawai Y., Oda N., Mano T., Hayakawa N., Kato R., Itoh Y., Shimazaki K., Kotake M., Nakai A., Hiramitsu S., Itoh M., Morimoto S., Nagasaka A. A case of myocarditis associated with IDDM. Diabetes Care 1996, 19(4):374-378.
53. Nielsen T.D., Steenbergen C., Russell S.D. Nonischemic cardiomyopathy associated with auto-immune polyglandular syndrome type II. Endocr. Pract. 2007, 13(1):59-62.
54. Niu J., Kolattukudy P.E. Role of MCP-1 in cardiovascular disease: molecular mechanisms and clinical implications. Clin. Sci. 2009, 117:95-109.
55. Osborn O., Olefsky J.M. The cellular and signaling networks linking the immune system and metabolism in disease. Nat. Med. 2012, 18(3):363-374.
56. Parihar A., Eubank T.D., Doseff A.I. Monocytes and macrophages regulate immunity through dynamic networks of survival and cell death. J. Innate Immun. 2010, 2(3):204-215.
57. Richardson P., McKenna W., Bristow M., Maisch B., Mautner B., O'Connell J., Olsen E., Thiene G., Goodwin J., Gyarfas I., Martin I., Nordel P. Report of the 1955 World Health Organization/International Society and Federation of Cardiology Task Force on the definition and classification of cardiomyopathies. Circulation 1996, 93(5):841-842.
58. Riggs T.W., Transue D. Doppler echocardiographic evaluation of left ventricular diastolic function in adolescents with diabetes mellitus. Am. J. Cardiol. 1990, 65(13):899-902.
59. Rolo A.P., Palmeira C.M. Diabetes and mitochondrial function: role of hyperglycemia and oxidative stress. Toxicol. Appl. Pharmacol. 2006, 212(2):167-178.
60. Rose N.R. Critical cytokine pathways. J. Interferon Cytokine Res. 2011, 31(10):1-6.
61. Rull A., Camps J., Alonso-Villaverde C., Joven J. Insulin resistance, inflammation, and obesity: role of monocyte chemoattractant protein-1 (or CCL2) in the regulation of metabolism. Mediat. Inflamm. 2010, 10.1155/2010/326580.
62. Saxena A., Chen W., Su Y., Rai V., Uche O.U., Li N., Frangogiannis N.G. IL-1 induces proinflammatory leukocyte infiltration and regulates fibroblast phenotype in the infarcted myocardium. J. Immunol. 2013, 191(9):4838-4848.
63. Schumann C., Faust M., Gerharz M., Ortmann M., Schubert M., Krone W. Autoimmune polyglandular syndrome associated with idiopathic giant cell myocarditis. Exp. Clin. Endocrinol. Diabetes 2005, 113(5):302-307.
64. Shirpoor A., Salami S., Khadem-Ansari M.H., Ilkhanizadeh B., Pakdel F.G., Khademvatani K. Cardioprotective effect of vitamin E: rescues of diabetes-induced cardiac malfunction, oxidative stress, and apoptosis in rat. J. Diabet. Complicat. 2009, 23(5):310-316.
65. Simonson M.S., Ismail-Beigi F. Endothelin-1increases collagen accumulation in renal mesangial cells by stimulating a chemokine and cytokine autocrine signaling loop. J. Biol. Chem. 2011, 286(13):11003-11008.
66. Soardo G., Donnini D., Domenis L., Catena C., De Silvestri D., Cappello D., Dibenedetto A., Carnelutti A., Bonasia V., Pagano C., Sechi L.A. Metab. Syndr. Relat. Disord. 2011, 9(5):397-401.
67. Talukder M.A., Norota I., Sakurai K., Endoh M. Inotropic response of rabbit ventricular myocytes to endothelin-1: difference from isolated papillary muscles. Am. J. Physiol. Heart Circ. Physiol. 2001, 281(2):H596-H605.
68. Tirosh A., Shai I., Afek A., Dubnov-Raz G., Avalon N., Gordon B., Derazne E., Tzur D., Shamis A., Vinker S., Rudich A. Adolescent BMI trajectory and risk of diabetes versus coronary disease. N. Engl. J. Med. 2011, 364(14):1315-1325.
69. Toshida T., Hanawa H., Toba K., Watanabe R., Yoshida K., Abe S., Kato K., Kodama M., Aizawa Y. Expression of immunological molecules by cardiomyocytes and inflammatory and interstitial cells in rat autoimmune myocarditis. Cardiovasc. Res. 2005, 68(2):278-288.
70. Turk Z. Glycotoxins, carbonyl stress and relevance to diabetes and its complications. Physiol. Res. 2010, 59(2):147-156.
71. Turk Z., Nemet I., Varga-Defteardarovic L., Car N. Elevated level of methylglyoxal during diabetic ketoacidosis and its recovery. Diabetes Metab. 2006, 32(2):176-180.
72. Valsania P., Zarich S.W., Kowalchuk G.J., Kosinski E., Warram J.H., Krolewski A.S. Severity of coronary artery disease in young patients with insulin-dependent diabetes mellitus. Am. Heart J. 1991, 123(3 Pt 1):695-700.
73. Viappiani S., Schulz R. Detection of specific nitrotyrosine-modified proteins as a marker of oxidative stress in cardiovascular disease. Am. J. Physiol. Heart Circ. Physiol. 2006, 290(6):H2167-2168.
74. Voros G., Ishaq M., Dens J. Spontaneous rupture of a papillary muscle in acute myocarditis. Acta Cardiol. 2011, 66(3):405-406.
75. Williamson C.L., Dabkowski E.R., Baseler W.A., Croston T.L., Alway S.E., Hollander J.M. Enhanced apoptotic propensity in diabetic cardiac mitochondria: influence of subcellular spatial location. Am. J. Physiol. Heart Circ. Physiol. 2010, 298(2):H633-H642.
76. Wojcik M., Rudzinski A., Starzyk J. Left ventricular diastolic dysfunction in adolescents with type 1 diabetes reflects the long-but not short term metabolic control. J. Pediatr. Endocrinol. Metab. 2010, 23(10):1055-1064.